Literature DB >> 15679281

Resuscitation of fat embolism syndrome with extracorporeal membrane oxygenation.

David P Webb1, Wes A McKamie, John B Pietsch.   

Abstract

Embolization of marrow fat appears to be an inevitable consequence of long bone fractures. Pulmonary fat embolism (FE) with cardiovascular collapse is associated with a high mortality rate because of acute right ventricular failure and hypoxia. Immediate and appropriate resuscitation is required to prevent sudden death. Although extracorporeal membrane oxygenation (ECMO) has been used for a multitude of applications involving respiratory and circulatory collapse, its full potential as a standard conventional therapy has yet to be exploited. Herein, we describe the successful use of veno-venous (V-V) ECMO in a trauma patient who initially presented with fractures of the right ulna and femur. After surgery, the patient rapidly decompensated despite massive ventilatory support and was placed on ECMO. ECMO support lasted approximately 120 hours followed by an uneventful recovery and discharge 10 days later.

Entities:  

Mesh:

Year:  2004        PMID: 15679281

Source DB:  PubMed          Journal:  J Extra Corpor Technol        ISSN: 0022-1058


  3 in total

1.  Perioperative support of a patient with fat embolism syndrome with extracorporeal membraneoxygenation.

Authors:  Ivor Popovich; Vikrant Singh; Bevan Vickery
Journal:  BMJ Case Rep       Date:  2019-05-14

2.  [Arteriovenous extracorporeal membrane oxygenation (ECMO). A therapeutic option for fulminant pulmonary embolism].

Authors:  J Swol; D Buchwald; A Ewers; T A Schildhauer
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-10-17       Impact factor: 0.840

Review 3.  Use of venovenous extracorporeal membrane oxygenation for perioperative management of acute respiratory distress syndrome caused by fat embolism syndrome: A case report and literature review.

Authors:  Kenta Momii; Yuji Shono; Kanji Osaki; Yoshinori Nakanishi; Takeshi Iyonaga; Masaaki Nishihara; Tomohiko Akahoshi; Yasuharu Nakashima
Journal:  Medicine (Baltimore)       Date:  2021-02-26       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.